Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Chen Gong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6082-5993, 0000-0001-8151-2179; OpenAlex author ID A5085543510. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Osteogenic-like Phenotypic Reprogramming Is Associated with Reduced Malignant Behaviors in Pancreatic Cancer Cells Involving MAPK-ERK Signaling. Co-author DOI 10.3390/ijms27114725↗
  2. Baicalein disrupts TGF-β-induced EMT in pancreatic cancer by FTO-dependent m6A demethylation of ZEB1. First author DOI 10.1016/j.bbamcr.2025.119969↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiping Wei · 1 shared paper, 2026 · strength 0.43
  2. Michael Schaefer · 1 shared paper, 2025 · strength 0.28
  3. Bin Yan · 1 shared paper, 2025 · strength 0.28
  4. Kangtao Wang · 1 shared paper, 2025 · strength 0.28
  5. Lian Zhao · 1 shared paper, 2025 · strength 0.28
  6. Ingrid Herr · 1 shared paper, 2025 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.